{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-014919","form_type":"8-K","ticker":"TPB","cik":"0001290677","company_name":"Turning Point Brands, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.852715+00:00","generated_at":"2026-05-22T07:15:41.797030+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Turning Point Brands Q1 net sales up 28% to $106.4M; raises Modern Oral guidance to $80-95M","bullets":["Net sales $106.4M (+28.1% YoY); diluted EPS $0.79 vs $0.63; Adj. diluted EPS $0.91 vs $0.80.","Adj. EBITDA $27.7M (+12.0% YoY); reaffirms FY2025 Adj. EBITDA guidance $108-113M.","Modern Oral sales $22.3M (nearly 10x YoY, nearly double Q4); guidance raised to $80-95M from $60-80M.","Stoker's segment net sales up 62.7% to $59.2M; volume +55.1%, price/mix +7.6%."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-014919","json":"https://secwatch.observer/filing/0001437749-25-014919.json","markdown":"https://secwatch.observer/filing/0001437749-25-014919.md","text":"https://secwatch.observer/filing/0001437749-25-014919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1290677/000143774925014919/0001437749-25-014919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1290677/000143774925014919/tpb20250506_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:15:41.797030+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}